302 related articles for article (PubMed ID: 26404253)
1. A Series of New Ligustrazine-Triterpenes Derivatives as Anti-Tumor Agents: Design, Synthesis, and Biological Evaluation.
Xu B; Chu F; Zhang Y; Wang X; Li Q; Liu W; Xu X; Xing Y; Chen J; Wang P; Lei H
Int J Mol Sci; 2015 Sep; 16(9):21035-55. PubMed ID: 26404253
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of ligustrazine - betulin amino-acid/dipeptide derivatives as anti-tumor agents.
Guo WB; Zhang H; Yan WQ; Liu YM; Zhou F; Cai DS; Zhang WX; Huang XM; Jia XH; Chen HS; Qi JC; Wang PL; Xu B; Lei HM
Eur J Med Chem; 2020 Jan; 185():111839. PubMed ID: 31708185
[TBL] [Abstract][Full Text] [Related]
3. Combination of amino acid/dipeptide with ligustrazine-betulinic acid as antitumor agents.
Xu B; Yan WQ; Xu X; Wu GR; Zhang CZ; Han YT; Chu FH; Zhao R; Wang PL; Lei HM
Eur J Med Chem; 2017 Apr; 130():26-38. PubMed ID: 28237794
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of Ligustrazine-Flavonoid Derivatives as Potential Anti-Tumor Agents.
Wang H; Zhang W; Cheng Y; Zhang X; Xue N; Wu G; Chen M; Fang K; Guo W; Zhou F; Cui H; Ma T; Wang P; Lei H
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200208
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
7. A New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3.
Zhang C; Yan W; Li B; Xu B; Gong Y; Chu F; Zhang Y; Yao Q; Wang P; Lei H
Int J Mol Sci; 2015 Jul; 16(7):16401-13. PubMed ID: 26193270
[TBL] [Abstract][Full Text] [Related]
8. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
[TBL] [Abstract][Full Text] [Related]
9. Amino acid derivatives of ligustrazine-oleanolic acid as new cytotoxic agents.
Chu F; Xu X; Li G; Gu S; Xu K; Gong Y; Xu B; Wang M; Zhang H; Zhang Y; Wang P; Lei H
Molecules; 2014 Nov; 19(11):18215-31. PubMed ID: 25387350
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.
Meng YQ; Zhang LF; Liu DY; Liu LW; Zhang Y; Zhao MJ
J Asian Nat Prod Res; 2016; 18(3):280-8. PubMed ID: 26524942
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and cytotoxicity of cell death mechanism of rotundic acid derivatives.
He YF; Nan ML; Sun JM; Meng ZJ; Li W; Zhang M
Bioorg Med Chem Lett; 2013 May; 23(9):2543-7. PubMed ID: 23558236
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity.
Szalóki G; Pantzou A; Prousis KC; Mavrofrydi O; Papazafiri P; Calogeropoulou T
Bioorg Med Chem; 2014 Dec; 22(24):6980-8. PubMed ID: 25456391
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
17. Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents.
Wang J; Hong G; Li G; Wang W; Liu T
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835359
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
Zhou F; Wu GR; Cai DS; Xu B; Yan MM; Ma T; Guo WB; Zhang WX; Huang XM; Jia XH; Yang YQ; Gao F; Wang PL; Lei HM
Eur J Med Chem; 2019 Sep; 178():623-635. PubMed ID: 31226654
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of oleanolic acid dimers linked at C-28 and evaluation of anti-tumor activity.
Cheng KG; Su CH; Yang LD; Liu J; Chen ZF
Eur J Med Chem; 2015 Jan; 89():480-9. PubMed ID: 25462260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
